Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genomics Laboratory, |
RCV005251525 | SCV005902217 | likely pathogenic | PIK3CA related overgrowth syndrome | 2024-08-30 | criteria provided, single submitter | clinical testing | A PIK3CA c.1353_1367del (p.Leu452_Leu456del) variant was identified at an allelic fraction consistent with somatic origin. This variant, to our knowledge, has not been reported in the medical literature. It is absent from the general population (gnomAD v.4.1.0), indicating it is not a common variant. This variant resides within a region, the C2 domain, of PIK3CA that is defined as a critical functional domain (Lai A et al., PMID: 35997716). The PIK3CA c.1353_1367del (p.Leu452_Leu456del) variant is predicted to cause a change in the length of the protein due to an in-frame deletion of five amino acids in a non-repeat region. Based on available information and an internally developed protocol informed by the ACMG/AMP guidelines for variant interpretation and gene-specific practices from the ClinGen Criteria Specification Registry (Leon-Quintero FZ et al., PMID: 39434542), the PIK3CA c.1353_1367del (p.Leu452_Leu456del) variant is classified as likely pathogenic. |